Clinical Trial Update: Nasal High Flow Therapy 30 Day Readmission Study [NA]

View source ↗

Summary

Clinical trial update for a nasal high-flow therapy study in COPD that was terminated; results posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Nasal high-flow therapy

Snippet

Sponsor: Fisher and Paykel Healthcare | Conditions: Chronic Obstructive Pulmonary Disease, COPD | NA | Status: TERMINATED | Results posted: 2020-07-24